Propel Bio Management as of Sept. 30, 2025
Portfolio Holdings for Propel Bio Management
Propel Bio Management holds 16 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Plains Gp Holdings Lp-cl Ltd Partnr Int A (PAGP) | 23.2 | $23M | 1.3M | 18.24 | |
| Achieve Life Sciences (ACHV) | 11.9 | $12M | 3.8M | 3.15 | |
| Akero Therapeutics (AKRO) | 10.9 | $11M | 229k | 47.48 | |
| Milestone Pharmaceuticals (MIST) | 10.3 | $10M | 5.1M | 2.00 | |
| Applied Therapeutics (APLT) | 6.8 | $6.8M | 11M | 0.60 | |
| Phathom Pharmaceuticals (PHAT) | 6.5 | $6.5M | 553k | 11.77 | |
| Abeona Therapeutics Com New (ABEO) | 5.1 | $5.1M | 974k | 5.28 | |
| Delcath Systems Com New (DCTH) | 4.7 | $4.7M | 439k | 10.75 | |
| Celldex Therapeutics Com New (CLDX) | 4.0 | $4.0M | 155k | 25.87 | |
| Tscan Therapeutics (TCRX) | 3.5 | $3.5M | 1.9M | 1.82 | |
| Compass Pathways Sponsored Ads (CMPS) | 2.9 | $2.9M | 510k | 5.73 | |
| Nektar Therapeutics Com New (NKTR) | 2.8 | $2.8M | 49k | 56.90 | |
| Jasper Therapeutics Com New (JSPR) | 2.5 | $2.4M | 1.0M | 2.38 | |
| Zevra Therapeutics Com New (ZVRA) | 2.2 | $2.2M | 232k | 9.51 | |
| Miragen Therapeutics (VRDN) | 1.9 | $1.9M | 90k | 21.58 | |
| Athira Pharma | 0.6 | $618k | 149k | 4.14 |
